December 23, 2014 by MassDevice staff
MassDevice.com asks medical device CEOs about the key issues of 2014 and what’s ahead for the New Year.
As 2014 draws to a close, MassDevice.com asked several medical device company CEOs for their takes on 2014 and what they’re looking for in 2015.
We wanted to get their views on the major trends seen in medtech this year, including the red-hot M&A and IPO scenes, the medical device tax, the regulatory environment in the U.S., and more.
Below please find the chief executives’ responses, edited for clarity:
1. Which technologies do you think we’ll be hearing about the most this coming year? What’s hot in the spaces your firm plays in?
Mike Mussallem, CEO of Edwards Lifesciences: Moving into 2015, I think you will continue to hear about disruptive innovation that allows patients to live healthier, happier lives. This year alone, we witnessed a number of impactful developments, such as an artificial retina for blind patients through an implant that stimulates the optic nerve and a motorized device that helps people with certain spinal cord injuries to walk. For Edwards, our aspiration is clear: we want to be a company that is recognized as transforming patient care through innovative technology. We look forward to continuing to offer life-changing heart valve replacement therapies, while also increasing our emphasis on mitral transcatheter valve replacement, heart failure and enhanced surgical recovery.
